This NDC is on FDA's drug shortage list (posted Jul 14, 2023)
Reported reason: Shortage of an active ingredient
Product Information
LISDEXAMFETAMINE 40 MG CAPSULE is a generic product labeled by Solco Healthcare US LLC, priced at $2.6298 per EA under NDC 43547060510. Its NADAC has been published 152 times since Sep 27, 2023.
FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547060510
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA216266FDA Approved
8/25/2023
TE Code
AB
On Market Since
8/26/2023
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has been published 152 times since Sep 27, 2023, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6298 per EA |
|---|---|
| All-time high | $6.5053 (Mar 13, 2024) |
| All-time low | $2.6298 (Aug 19, 2026) |
| 52-week high | $3.7294 |
| 52-week low | $2.6298 |
| Median price | $4.0402 |
| Average price | $4.0242 |
| Largest weekly change | +41.6% (Jan 17, 2024) |
| Weeks tracked | 152 |
| Tracking since | Sep 27, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lisdexamfetamine dimesylate capsules market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 40 MG CAPSULE, manufactured by Solco Healthcare US LLC, is $2.6298 per EA (NDC 43547060510), effective Aug 19, 2026.
How has the price of LISDEXAMFETAMINE 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has declined 21.1%. It has been tracked across 152 weekly CMS publications since Sep 27, 2023.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 40 MG CAPSULE?
Since Sep 27, 2023, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has ranged from a low of $2.6298 (Aug 19, 2026) to a high of $6.5053 (Mar 13, 2024), with a median of $4.0402 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 40 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LISDEXAMFETAMINE 40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LISDEXAMFETAMINE 40 MG CAPSULE?
LISDEXAMFETAMINE 40 MG CAPSULE (NDC 43547060510) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Is LISDEXAMFETAMINE 40 MG CAPSULE in shortage?
Yes — NDC 43547060510 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Shortage of an active ingredient.